INSIGHTS ON ENTERPRISE SOLUTIONS
-
Selecting The Right pDNA Supplier: 10 Key Factors To Consider
Selecting the right pDNA supplier is a critical decision that can significantly impact the success of your project or research. Consider these 10 key factors to help you make an informed choice.
-
A CDMO’s Checklist For Prospective Clients: Part 3
In the last entry of our client checklist series, we delve into crucial aspects such as project management, decision-making, MSA negotiations, and building trust in CDMO-client partnerships.
-
A CDMO’s Checklist For Prospective Clients: Part 2
In Part 2 of our series, we delve deeper into the crucial elements of transparency that prospective clients should consider when partnering with a CDMO, including analytics, documentation, and more.
-
A CDMO’s Checklist For Prospective Clients: Part 1
Ever wondered about the flip side of client-CDMO dynamics? In this series, discover why transparency is vital for both parties in a fruitful partnership.
-
Idea To Clinic: Accelerate Your Manufacturing Timeline To FIH Studies3/11/2024
Translating novel drug discoveries into clinical trials remains a complex endeavor. Learn how a CDMO with cutting-edge technologies can facilitate a smooth path from discovery to FIH studies.
-
Accelerating The Development And Production Of High-Quality Bispecific Antibodies3/7/2024
bsAbs are revolutionizing medicine by targeting two disease mechanisms simultaneously. Learn how an innovative platform offers excellent pairing and significantly enhances productivity and quality.
-
Single-Use Microbial Impactor On A Filling Line3/6/2024
Discover the advantages of a single-use microbial impactor through a demonstration of its ease of use in an isolator and an explanation of its ability to eliminate false positives.
-
A Scalable Single-Use Two-Step pDNA Purification Process3/6/2024
Evaluate the performance of a single-use two-step plasmid purification process, and see how it compares to the existing three-step purification method.
ENTERPRISE SOLUTIONS
-
Discover CTDMO services that establish robust, integrated, and consistent processes across all stages, enabling you to fast-track the advancement of your mRNA-based vaccines and therapeutics.
-
Learn how our expertise in high-yield suspension cell lines, robust lentiviral vector production, and extensive quality control measures can expedite your innovative lentiviral vector programs.
-
Understand and predict human response for your drug candidates with expert help. Explore contract research services for researchers seeking to harness the advantages of organ-on-a-chip technology.
-
The COVID-19 pandemic highlighted the urgent need for a quick, efficient, and scalable vaccine production process. Resilience's Vaccine Path-To-PAD (Process and Analytical Development) program provides a clear and easy path to maximize yields at the beginning of development, with deep expertise in vaccines, robust expression platforms, and high-quality Vero and Quail cell lines.
-
At Abzena, the leading CDMO + CRO for complex biologics and bioconjugates, our focus is on providing a de-risked and streamlined development pathway for our customers.